LGND holders · CITADEL ADVISORS LLC 13F · LGND stock
CITADEL ADVISORS LLC Ligand Pharmaceuticals Incorporated (LGND) 13F holding
CITADEL ADVISORS LLC reported 6,596 LGND shares valued at $1.3M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest LGND 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the LGND holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 6,596 | $1.3M | COM NEW |
| 2025-12-31 | 2,066 | $390.6K | COM NEW |
| 2025-09-30 | 13,312 | $2.4M | COM NEW |
| 2025-06-30 | 41,906 | $4.8M | COM NEW |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.